Ειδήσεις: GENE THERAPY | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

31/03 18:06 yahoo.com

Why Alnylam Pharmaceuticals Inc. (ALNY) is One of the Best High Growth Healthcare Stocks to Buy Now

Alnylam RNAi high‑growth biotech healthcare stocks gene therapy

29/03 02:57 sciencedaily.com

This new therapy turns off pain without opioids or addiction

gene therapy pain relief AI mapping opioid‑free non‑addictive brain targeting

27/03 18:16 yahoo.com

Clearbridge Small Cap Growth Strategy Added Dyne Therapeutics (DYN) in Q4

Clearbridge Small Cap Growth Strategy Dyne Therapeutics DYN biotech gene therapy Q4 addition

27/03 16:47 cbsnews.com

Their 3 kids kept getting sick. A new gene therapy offered hope

gene therapy rare disorder clinical trial Langenhop family hope pediatric genetics

27/03 15:25 statnews.com

STAT+: Pharmalittle: We’re reading about Novo Nordisk boosting consumer focus, FDA approving a gene therapy, and more

Novo Nordisk FDA gene therapy consumer focus personalized medicine biotech

27/03 13:07 investing.com

Rocket Pharmaceuticals stock gains on FDA gene therapy approval

Rocket Pharmaceuticals FDA approval gene therapy stock gains rare disease investor confidence

27/03 02:42 statnews.com

STAT+: FDA approves Rocket gene therapy for rare immune disorder

FDA approval gene therapy LAD‑1 Rocket Pharma Kresladi rare disease

26/03 08:04 defenseworld.net

Ocugen Shares Phase II OCU410 Data Showing 31% Slower GA Lesion Growth at 12 Months

Ocugen OCU410 geographic atrophy dry age‑related macular degeneration gene therapy Phase II

25/03 16:30 statnews.com

STAT+: Sarepta Therapeutics shares rise on early promise for rare disease drugs

Sarepta Therapeutics muscular dystrophy early clinical trials drug safety drug efficacy share price surge

25/03 16:30 statnews.com

STAT+: Sarepta Therapeutics shares rise on early promise for rare disease drugs

Sarepta Therapeutics muscular dystrophy early clinical trials drug safety drug efficacy share price surge

Loading...